REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 31st, 2022 • Xtant Medical Holdings, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 25, 2022, by and among Xtant Medical Holdings, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
XTANT MEDICAL HOLDINGS, INC. Belgrade, Montana 59714 August 25, 2022Xtant Medical Holdings, Inc. • August 31st, 2022 • Biological products, (no disgnostic substances) • Delaware
In connection with that certain Securities Purchase Agreement dated as of August 23, 2022 among Xtant Medical Holdings, Inc. (the “Company) and the purchasers party thereto (the “Purchase Agreement”), including you (the “Nominee”), the Board of Directors (the “Board”) of the Company is considering expanding the size of the Board by one (1) position, nominating you to fill the newly-created position on the Board, and electing you to the position of Chairman of the Board, in each case effective upon completion of the First Closing, as defined under and pursuant to the Purchase Agreement (the “First Closing”). Subject to the Nominee’s agreement with the terms and conditions set forth in this letter agreement (the “Letter Agreement”), the Board has instructed me to inform you that it will vote to expand the size of the Board by one (1) position, appoint the Nominee to fill the newly-created position and elect the Nominee to the position of Chairman of the Board.
